Dr. Reddy's Laboratories Faces Mixed Performance Amid Competitive Pharmaceutical Landscape
Dr. Reddy's Laboratories has seen significant trading activity, maintaining its opening price after three days of gains. The stock is above several short-term moving averages but below the 200-day average. With a market cap of Rs 1,03,121.99 crore, its P/E ratio is notably lower than the industry average.
Dr. Reddy's Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced notable activity today, underperforming the sector by 0.48%. The stock, which opened at Rs 1248.15, has maintained this price throughout the trading session, marking a reversal after three consecutive days of gains. In terms of moving averages, Dr. Reddy's stock is currently above the 5-day, 20-day, 50-day, and 100-day averages, yet remains below the 200-day moving average, indicating mixed short-term performance trends.
With a market capitalization of Rs 1,03,121.99 crore, the company has a price-to-earnings (P/E) ratio of 18.47, significantly lower than the industry average of 34.50. Over the past year, Dr. Reddy's Laboratories has recorded a performance of 6.76%, lagging behind the Sensex's 9.24%.
In the broader Pharmaceuticals & Drugs sector, 166 stocks have reported results, with 75 showing positive outcomes, 55 flat, and 36 negative. This context highlights the competitive landscape in which Dr. Reddy's operates.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
